Filing Flows › Pyxis Oncology (PYXS) › Recalls, complaints & regulation
Pyxis Oncology (PYXS): clinical trials
Pyxis Oncology (PYXS) beyond its filings: 3 active clinical trials.
Pyxis Oncology's latest quarter
Pyxis Oncology, Q4 2025: revenue $11.0M, operating margin -165.7%, net loss $18.1M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Pyxis Oncology have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.